Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial.

Annals of the rheumatic diseases·2023

Same author

Effectiveness and safety of rituximab in Takayasu arteritis: a multicenter retrospective study.

Joint bone spine·2023

Same author

European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS).

European stroke journal·2023

Same author

Polymyalgia rheumatica.

Lancet (London, England)·2023

Same author

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.

Arthritis research & therapy·2023

Same author

Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional study.

RMD open·2023

Search research articles

Video Experimental Relacionado

Updated: Jul 3, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

La polimialgia reumática y la arteritis de células gigantes.

Carlo Salvarani¹, Fabrizio Cantini, Gene G Hunder

¹Unit of Rheumatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy. salvarani.carlo@asmn.re.it

Lancet (London, England)

|July 22, 2008

Resumen

La polimialgia reumática y la arteritis de células gigantes son afecciones inflamatorias relacionadas. Los glucocorticosteroides son el tratamiento primario, pero el uso a largo plazo causa eventos adversos, lo que requiere nuevos objetivos terapéuticos.

Videos de Experimentos Relacionados

Last Updated: Jul 3, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Área de la Ciencia:

Reumatología Reumatología.
Inmunología Inmunología.
La medicina vascular es una medicina vascular.

Sus antecedentes:

La polimialgia reumática (PMR) y la arteritis de células gigantes (GCA) son trastornos inflamatorios que afectan a los adultos mayores.
Estas condiciones a menudo co-ocurren y comparten etiologías desconocidas, potencialmente involucrando factores genéticos y ambientales.
La PMR implica sinovitis, mientras que la GCA afecta a la aorta y sus ramas, presentándose con diversos síntomas neurológicos y vasculares.

Objetivo del estudio:

Para revisar la comprensión actual de la polimialgia reumática y la arteritis de células gigantes.
Para discutir el tratamiento establecido y sus limitaciones.
Para resaltar la necesidad de nuevas estrategias terapéuticas.

Principales métodos:

Revisión de la literatura sobre la polimialgia reumática y la arteritis de células gigantes.
Análisis de las manifestaciones clínicas y la patogénesis.
Evaluación de las modalidades actuales de tratamiento y sus efectos adversos.

Principales resultados:

Los glucocorticosteroides son el tratamiento principal tanto para la PMR como para la GCA.
A menudo se requiere terapia con glucocorticosteroides a largo plazo, lo que lleva a eventos adversos en más del 50% de los pacientes.
Los ensayos de medicamentos ahorradores de esteroides han mostrado resultados inconsistentes.

Conclusiones:

Una comprensión más profunda de la patogénesis molecular de PMR y GCA es crucial.
La identificación de nuevos objetivos moleculares es esencial para desarrollar terapias más efectivas y seguras.
La investigación futura debe centrarse en estrategias de tratamiento innovadoras más allá de los glucocorticosteroides.